Hadassah

Hadassah Melanoma Specialist Awarded Grant for Advanced Research

Tuesday, Apr 28 2015

Renowned for successfully treating patients in advanced stages of melanoma with a personalized vaccine, Dr. Michal Lotem, Hadassah Medical Organization Senior Dermatologist and Oncologist and head of its Center for Melanoma and Cancer Immunotherapy, has been awarded a grant from the prestigious Melanoma Research Alliance (MRA). Based in New York, MRA contributes several million dollars every year to promising researchers in the field of melanoma, but recipients are normally based out of the United States.

The grant, $337,500 over three years, was given to the Hadassah team, including Dr. Galit Eisenberg and Dr. Roni Engelstein. Its intended use will be chiefly to find the best method of treating melanoma under lab conditions and then to identify a medication that will prove effective against the disease in patients.

The research concept involves a receptor found on the surface of inflamed cells that Dr. Lotem and her research team located. This receptor regulates the actions the cells can take. The Hadassah team has also found a way to activate this receptor, stimulating it to accelerate an individual’s immune response against melanoma cells.

"We are talking about a new direction,” explains Dr. Lotem. “The receptor and the importance of its biological activity is what stands at the center of our research, done in cooperation with the researchers from the Hebrew University—Prof. Michal Baniyash and Dr. Ofra Benny.”

While an ambitious goal, the Hadassah team is optimistic. “Today we are seeing a revolution in the treatment of melanoma.” notes Dr. Lotem, “The Hadassah Medical Organization is among the world leaders because we always believed that the immune system can combat cancer. In recent years, we have found just how great the importance of the immune system is in eradicating cancer. Therefore, every discovery that confirms our line of research opens an additional treatment approach—great news for patients who now have the possibility to receive the help they need.”

Dr. Lotem worked as a fellow at the National Cancer Institute in Bethesda, Maryland, under the mentorship of Dr. Stewart Rosenberg, a pioneer and leader of modern cancer immunotherapy. Fortified with this training, she returned to Hadassah and developed personalized melanoma vaccines using the patient’s own tumor cells. She has been using different generations of these vaccines to treat advanced cases of the disease for 16 years. The 2014 version of the personalized melanoma vaccine is genetically engineered with state-of-the-art immunology to produce a stronger immune response to the tumor.

The vaccines have proven to stop the progression and/or recurrence of melanoma for over 200 patients.

Hadassah is also beginning to treat patients with an even more advanced therapy for metastatic melanoma that was developed by Dr. Rosenberg and is available in only about a dozen medical facilities worldwide. Employing adoptive transfer of Tumor Infiltrating Lymphocytes (TILs), this treatment, called TIL therapy, is based on releasing immune cells from the melanoma tumor and expanding these cells to billions more in a specialized laboratory. The cells are then transplanted back into the patient.

Hadassah is also working on vaccines for lung, ovarian, colon, and breast cancers. Because Hadassah has a huge bank of tumor lines, coupled with expertise, it is well positioned to create new vaccines.

Comments

From: Dimitra Stefanoudaki on June 28, 2015
Good morning, my name is Dimitra Stefanoudaki and I am 58 yrs old and I am from Athens, Greece. My medical history is the following: In 1998, the diagnosis was on the LEFT tibia, malignant melanoma in situ. I had surgery and everything went well for 25 years. In november 2012 the doctors removed my uterus because of thick endometrium. In March 2013 an inguinal glands melanoma was found again; the biopsy was possitive for melanoma and staging showed swollen metastatic lymph nodes on the LEFT pelvis and paraaortal area. The BRAF gene mutation test was possitive and Ι was prescribed with ZELBORAF. Can you tell me please where I can find more informations about the vaccine for melanoma? Thanks and I am looking forward for your answer.. Kind regards Dimitra Stefanoudaki
From: Stewart Greenberg on April 30, 2015
As one of Dr. Lotem's patients who was admitted into her protocol three years ago I can catagorically tell everyone what an amazing person, doctor, and human being Dr. Lotem is. HMO should feel honored to have her on its staff. I was given only three months to live when I first consulted with Dr. Lotem. She was the only doctor who provided hope to my family and me. May she be allowed to continue her amazing research, and help so many cancer patients. The world needs more physicians such as Dr. Lotem .
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Sep 28 2016

Hadassah Medical Organization Goes on High Alert for Peres Funeral

Thousands of visitors, including high profile dignitaries, are expected to arrive in Jerusalem for the funeral of past Prime Minister and President Shimon Peres, who will be laid to rest on Friday, September 30.

READ MORE ›
alt_text

Friday, Sep 23 2016

2016 Graduates from 19 Countries Celebrate Hadassah’s IMPH Program

Singing "It's a Wonderful Country" in Hebrew, wearing their native dress, the members of the 41st International Master of Public Health (IMPH) program of the Hadassah-Hebrew University Braun School of Public Health and Community Medicine celebrated their graduation.

READ MORE ›
alt_text

Monday, Sep 19 2016

Hadassah Hospital Treats Terror Victims After Stabbing Attacks

This last week has brought a burst of terror attacks.

READ MORE ›
alt_text

Thursday, Sep 15 2016

2012 Hadassah Stage-Four Melanoma Patient Thankfully Healthy

"Doctors in Florida who pronounced me ‘soon-dead’ can't believe that I'm healthy today,” said Hadassah melanoma patient Stewart Greenberg.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More